Olodaterol Hydrochloride; Tiotropium Bromide Patent Expiration
Olodaterol Hydrochloride; Tiotropium Bromide is Used for managing symptoms of chronic obstructive pulmonary disease (COPD) and treating respiratory complaints. It was first introduced by Boehringer Ingelheim Pharmaceuticals Inc
Olodaterol Hydrochloride; Tiotropium Bromide Patents
Given below is the list of patents protecting Olodaterol Hydrochloride; Tiotropium Bromide, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Stiolto Respimat | US8733341 | Atomizer and method of atomizing fluid with a nozzle rinsing mechanism | Oct 16, 2030 | Boehringer Ingelheim |
Stiolto Respimat |
US7837235 (Pediatric) | Device for clamping a fluidic component | Sep 13, 2028 | Boehringer Ingelheim |
Stiolto Respimat | US7837235 | Device for clamping a fluidic component | Mar 13, 2028 | Boehringer Ingelheim |
Stiolto Respimat |
US7396341 (Pediatric) | Blocking device for a locking stressing mechanism having a spring-actuated output drive device | Apr 10, 2027 | Boehringer Ingelheim |
Stiolto Respimat | US9027967 | Device for clamping a fluidic component | Mar 31, 2027 | Boehringer Ingelheim |
Stiolto Respimat | US7727984 | Medicaments for the treatment of chronic obstructive pulmonary disease | Jan 19, 2027 | Boehringer Ingelheim |
Stiolto Respimat | US7396341 | Blocking device for a locking stressing mechanism having a spring-actuated output drive device | Oct 10, 2026 | Boehringer Ingelheim |
Stiolto Respimat | US7896264 | Microstructured high pressure nozzle with built-in filter function | May 26, 2025 | Boehringer Ingelheim |
Stiolto Respimat | US7220742 | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments | May 12, 2025 | Boehringer Ingelheim |
Stiolto Respimat | US8034809 | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments | May 12, 2025 | Boehringer Ingelheim |
Stiolto Respimat |
US7284474 (Pediatric) | Piston-pumping system having o-ring seal properties | Feb 26, 2025 | Boehringer Ingelheim |
Stiolto Respimat | US7284474 | Piston-pumping system having o-ring seal properties |
Aug 26, 2024
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US7056916 | Medicaments for the treatment of chronic obstructive pulmonary disease |
Dec 07, 2023
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US7491719 | Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments |
Nov 10, 2023
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US7786111 | Medicaments for the treatment of chronic obstructive pulmonary disease |
Nov 10, 2023
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US8044046 | Medicaments for the treatment of chronic obstructive pulmonary disease |
Nov 10, 2023
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US7988001 | Container provided with a pressure equalization opening |
Aug 04, 2021
(Expired) | Boehringer Ingelheim |
Stiolto Respimat |
US6988496 (Pediatric) | Cartridge for a liquid |
Aug 23, 2020
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US6988496 | Cartridge for a liquid |
Feb 23, 2020
(Expired) | Boehringer Ingelheim |
Stiolto Respimat |
US7802568 (Pediatric) | Cartridge for a liquid |
Aug 26, 2019
(Expired) | Boehringer Ingelheim |
Stiolto Respimat |
US6846413 (Pediatric) | Microstructured filter |
Feb 28, 2019
(Expired) | Boehringer Ingelheim |
Stiolto Respimat |
US6977042 (Pediatric) | Microstructured filter |
Feb 28, 2019
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US7802568 | Cartridge for a liquid |
Feb 26, 2019
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US6846413 | Microstructured filter |
Aug 28, 2018
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US6977042 | Microstructured filter |
Aug 28, 2018
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | USRE39820 | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
Jan 30, 2018
(Expired) | Boehringer Ingelheim |
Stiolto Respimat |
US6149054 (Pediatric) | Mechanical counter for a metering apparatus |
Jun 19, 2017
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US6149054 | Mechanical counter for a metering apparatus |
Dec 19, 2016
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US6453795 | Locking mechanism for a spring-actuated device |
Dec 05, 2016
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US5964416 | Device for producing high pressure in a fluid in miniature |
Oct 04, 2016
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US6176442 | Device for mounting a component exposed to a pressurized fluid |
Oct 04, 2016
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US6726124 | Device for producing high pressure in a fluid in miniature |
Oct 04, 2016
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US7104470 | Device for producing high pressure in a fluid in miniature |
Oct 04, 2016
(Expired) | Boehringer Ingelheim |
Stiolto Respimat | US7246615 | Atomising nozzle and filter and spray generating device |
May 31, 2016
(Expired) | Boehringer Ingelheim |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Olodaterol Hydrochloride; Tiotropium Bromide's patents.
Latest Legal Activities on Olodaterol Hydrochloride; Tiotropium Bromide's Patents
Given below is the list recent legal activities going on the following patents of Olodaterol Hydrochloride; Tiotropium Bromide.
Activity | Date | Patent Number |
---|---|---|
Payment of Maintenance Fee, 12th Year, Large Entity | 19 Apr, 2023 | US8044046 |
Payment of Maintenance Fee, 12th Year, Large Entity | 03 Apr, 2023 | US8034809 |
Payment of Maintenance Fee, 12th Year, Large Entity | 23 Feb, 2022 | US7786111 |
Payment of Maintenance Fee, 12th Year, Large Entity | 24 Nov, 2021 | US7727984 |
Payment of Maintenance Fee, 12th Year, Large Entity | 11 Aug, 2020 | US7491719 |
Patent Term Extension Certificate Critical | 16 Dec, 2019 | US7727984 |
Payment of Maintenance Fee, 8th Year, Large Entity | 16 Apr, 2019 | US8044046 |
Payment of Maintenance Fee, 8th Year, Large Entity | 02 Apr, 2019 | US8034809 |
Notice of Final Determination -Eligible | 02 Apr, 2019 | US7727984 |
Payment of Maintenance Fee, 12th Year, Large Entity | 14 Nov, 2018 | US7220742 |